Business Context and Reporting Period
This Form 13F-HR filing is submitted by Piper Jaffray Companies (referenced as Piper Sandler Companies in metadata) for the calendar quarter ended December 31, 2007. The report was signed by Greg Meyer, Controller, on February 11, 2008. It details the institutional investment manager's holdings in equity securities and convertible debt.
Key Financial Metrics
As a Form 13F filing, this document reports portfolio holdings rather than the company's own operating financials (revenue, profit, cash flow). The following metrics reflect the reported portfolio:
- Total Portfolio Value: $106,532,000 (reported as $106,532 in thousands).
- Total Number of Holdings: 160 entries.
- Discretionary Authority: All reported holdings are listed under "Sole" discretionary authority.
- Asset Composition: The portfolio consists of common stock ("SH") and various corporate notes/bonds ("PRN").
Material Changes and Portfolio Composition
The filing does not provide comparative data against the prior quarter (September 30, 2007) to determine material changes in holdings. However, the current portfolio composition reveals the following:
- Top Equity Holdings by Value:
- NYSE Euronext: $4,866,000 (55,440 shares).
- Yahoo Inc. (Front 4/0 Note): $5,237,000 (4,500,000 principal).
- Euronet Worldwide Inc. (Common): $1,571,000 (52,366 shares).
- Albany International Corp: $987,000 (26,600 shares).
- Significant Debt Holdings: The portfolio includes substantial positions in corporate notes, including Alexion Pharmaceuticals ($6.39M), American Medical Systems ($4.10M), and Core Laboratories LP ($6.41M).
- Derivatives: One position in Ocwen Financial Corp is listed with "PUT" authority.
Guidance, Outlook, and Risks
This filing is a statutory disclosure of holdings and does not contain management commentary, forward-looking guidance, risk factors, or contingency plans regarding the reporting manager's business operations. It strictly lists securities held at the end of the reporting period.
Investor Verification Checklist
- Verify the total portfolio value of $106.5 million against the firm's broader asset management capabilities.
- Confirm the concentration risk in specific sectors, notably Technology (e.g., Yahoo, NYSE Euronext) and Healthcare/Pharma (e.g., Alexion, Amgen-related notes).
- Note the significant exposure to convertible notes and corporate debt, which may indicate a specific credit strategy distinct from pure equity long-only funds.
- Check subsequent filings to determine if the "PUT" position in Ocwen Financial Corp was exercised or closed.